JBF Capital, Inc.
Source: SEC Form 13F · as of Mar 2026JBF Capital, Inc. holds 13 biotech & pharma companies tracked by BioSniper, totaling $16.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$16.4M
| Company | Shares | Value |
|---|---|---|
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 100,200 | $5.8M |
| REGNREGENERON PHARMACEUTICALS, INC. | 5,000 | $3.9M |
| LLYELI LILLY & Co | 3,000 | $2.8M |
| CNTACentessa Pharmaceuticals plc | 20,887 | $830K |
| APLSApellis Pharmaceuticals, Inc. | 20,532 | $826K |
| VMDViemed Healthcare Inc. | 43,578 | $401K |
| COYACoya Therapeutics, Inc. | 100,006 | $394K |
| GMOptec International, Inc. | 5,000 | $373K |
| ABUSArbutus Biopharma Corp | 80,281 | $361K |
| STIMNeuronetics Inc. | 233,166 | $338K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 900 | $244K |
| PRTAPROTHENA CORP PUBLIC LTD CO | 10,285 | $100K |
| LSTALISATA THERAPEUTICS, INC. | 13,234 | $66K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.